Importantly, knockdown of HNRNPM or SRSF3 lowered DHX9 protein levels, decreased the viability and proliferation of an Ewing sarcoma cell line, and rendered the cells more sensitive to chemotherapeutics. Here, DHX9 is linked to Ewing sarcoma.